Agilent Technologies (A) EBT Margin (2010 - 2026)
Agilent Technologies (A) posted quarterly EBT Margin of 22.23% for Q2 2026, up 665.0% year-over-year from 2.91% in Q2 2025, and up 9.83% quarter-over-quarter from 20.24% in Q1 2026.
Agilent Technologies (A) EBT Margin (2010 - 2026) Analysis & Trends
Agilent Technologies (A) has reported EBT Margin for 17 consecutive years, with 22.23% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBT Margin rose 665.0% year-over-year to 22.23%; the TTM figure through Apr 2026 stood at 21.85% (up 116.0% YoY), while the FY2025 annual figure was 20.65%, down 271.0% from the prior year.
- EBT Margin grew to 22.23% in Q2 2026 per A's latest filing, from 20.24% in the prior quarter.
- Across five years, EBT Margin topped out at 24.88% in Q4 2023 and bottomed at 7.89% in Q3 2023.
- Historically, EBT Margin has averaged 21.32% across 5 years, with a median of 22.1% in 2023.
- Annual changes were most pronounced in 2023 — EBT Margin plunged 1521 bps — and 2024, when it soared 1384 bps.
- Agilent Technologies' EBT Margin stood at 24.61% in 2022, then grew by 1 bps to 24.88% in 2023, then retreated by 5 bps to 23.57% in 2024, then increased by 1 bps to 23.75% in 2025, then declined by 6 bps to 22.23% in 2026.
- Business Quant data shows A's EBT Margin at 22.23% in Q2 2026, 20.24% in Q1 2026, and 23.75% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn | 13.54% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 9.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 22.23% |
| Jan 31, 2026 | 20.24% |
| Oct 31, 2025 | 23.75% |
| Jul 31, 2025 | 21.06% |
| Apr 30, 2025 | 15.59% |
| Jan 31, 2025 | 21.83% |
| Oct 31, 2024 | 23.57% |
| Jul 31, 2024 | 21.74% |
| Apr 30, 2024 | 23.78% |
| Jan 31, 2024 | 24.31% |
| Oct 31, 2023 | 24.88% |
| Jul 31, 2023 | 7.89% |
| Apr 30, 2023 | 21.96% |
| Jan 31, 2023 | 23.35% |
| Oct 31, 2022 | 24.61% |
| Jul 31, 2022 | 23.11% |
| Apr 30, 2022 | 20.72% |
| Jan 31, 2022 | 19.06% |
| Oct 31, 2021 | 26.99% |
| Jul 31, 2021 | 20.62% |